The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports


Biopharma Makes 'Solid Clinical Progress' in Q2/21

Research Report
  ()
The highlights of Oryzon Genomics' Q2/21 clinical advancements were recapped in a Roth Capital Partners report. read more >

US-Based Biopharma 'In Full Reset Mode,' Analyst Says

Research Report
  ()
An H.C. Wainwright & Co. report notes that Agios Pharmaceuticals "is rapidly rebooting and has made critical progress on various fronts." read more >

Novavax Shares Get a Boost as EC Orders up to 200 Million Doses of Its COVID-19 Vaccine

  ()
Novavax Inc. shares traded nearly 19% higher after the company reported the finalization of an advance purchase agreement with the European Commission to provide up to 200 million doses of its COVID-19 Vaccine. read more >

Translate Bio Shares Rise 29% on Sanofi's $3.2 Billion Buyout Bid

  ()
Shares of Translate Bio Inc. soared to a new 52-week high after the company reported it agreed to be acquired by its collaborative partner Sanofi SA for $38 per share in cash in a deal valued at $3.2 billion. read more >

Gene Editing May Terminate Virus Transmission, Combat Heart and Brain Disease With a Single Shot

Contributed Research
  ()
McAlinden Research Partners explores the acceleration of gene-editing technology and notes the market is poised to expand as the World Health Organization (WHO) creates new standards for companies to follow. read more >

Annovis Shares Rise on Positive Phase 2 Alzheimer's and Parkinson's Disease Trial Results

  ()
Shares of Annovis Bio Inc. traded 20% higher after the company reported positive interim data from its Phase 2 clinical studies of ANVS401 (Posiphen) for treatment of Alzheimer's and Parkinson's diseases. read more >

Sorrento Therapeutics Proceeds with COVID-19 Drug Treatment Trial

Research Report
  ()
The latest developments concerning Sorrento Therapeutics, its product portfolio and partners are summarized in a Dawson James Securities report. read more >

Biopharma Creates New Business Unit Ahead of Commercial Product Launch

Research Report
  ()
The purpose of HTG Molecular Diagnostics' new therapeutics division and early interest in the biopharma's commercial-ready Transcriptome Panel are covered in an H.C. Wainwright & Co. report. read more >

Small Bio-tech Gets $17.7 Million Backing from U.S. Department of Defense to Treat SARS-CoV-2 Delta Variant

  ()
Immunome's proprietary discovery engine identifies novel therapeutic antibodies and their targets. read more >

Cytokinetics Shares Rise 41% on Positive Phase 2 Redwood-HCM Trial Data

  ()
Cytokinetics Inc. shares reached a new 52-week high after the company reported positive topline results from its Phase 2 CK-274 hypertrophic cardiomyopathy clinical trial. read more >

Merger of Two Biopharmas 'Brings a New Dawn'

Research Report
  ()
The implications of the Aerpio Pharmaceuticals–Aadi Bioscience transaction and the outlook and future for the combined company's lead drug candidate are discussed in an H.C. Wainwright & Co. report. read more >

FDA, EMA Approve Drug Firm's Phase 3 Liver Cancer Trial Design

Research Report
  ()
The recent news regarding Can-Fite BioPharma is reviewed in a Dawson James Securities report. read more >

Alphatec Shares Rise After Firm Announces Strong Organic Revenue Growth in Q2

  ()
Alphatec Holdings Inc. shares traded 12% higher after the company reported preliminary Q2/21 financial results that included a larger than 90% increase in YoY organic revenue. read more >

Pharma Company Working to Unlock Psychedelic Drug's Potential for Stroke Recovery

  ()
Algernon Pharmaceuticals CEO Christopher J. Moreau and Dr. David Nutt, the company's research stroke consultant, discuss Algernon's upcoming Phase 1 study of DMT for stroke. read more >

Biopharma Files New Drug Application for Lead Clinical Product

Research Report
  ()
A review of Daré Bioscience's lead clinical product for bacterial vaginosis and a potential timeline to commercialization are provided in a ROTH Capital Partners report. read more >

Biotech 'Strikes Again,' Identifies Gene Mutation that Protects Against Obesity

Research Report
  ()
The encouraging work Regeneron Pharmaceuticals completed thus far, and the next challenge in this program, are laid out in an H.C. Wainwright & Co. report. read more >

Biohaven Posts Revenue of $93 Million in Q2 for Its Migraine Medicine

  ()
Shares of Biohaven Pharmaceutical Holding Co. Ltd. traded 12% higher to a new 52-week high after the company reported preliminary Q2/21 net product revenue of $93 million for NURTEC ODT, which it claims is the first and only FDA approved medicine for both acute and preventive migraine treatment. read more >

ALX Oncology Shares Rise on Positive Response and Survival Data in Phase 1b Gastric Cancer Trial

  ()
Shares of ALX Oncology Holdings Inc. traded 10% higher after the company reported new data from its Phase 1b ASPEN-01 study of ALX148 demonstrated a robust objective response in patients with gastric or gastroesophageal junction cancer. read more >

Alector Partners with GSK to Develop Monoclonal Antibodies for Neurodegenerative Diseases

  ()
Alector Inc. shares traded 59% higher after the company announced it entered into a global collaboration agreement with GlaxoSmithKline to develop and advance two first-in-class, clinical stage monoclonal antibodies for treating neurodegenerative diseases including frontotemporal dementia, amyotrophic lateral sclerosis, Parkinson's and Alzheimer's. read more >

Coverage Initiated on Developer of Psychedelic Drugs for PTSD, Smoking Cessation

Research Report
  ()
The investment thesis for Mydecine Innovations Group is presented in a ROTH Capital Partners report. read more >

Biotech Takes a 'Disruptive Drug Development Approach' to Destroy Dysregulated Transcription in Cancer

Research Report
  ()
Kronos Bio's key assets are reviewed in an H.C. Wainwright & Co. report. read more >

Diverse Pipeline for Repurposing Drug Company Includes Treatments for Idiopathic Pulmonary Fibrosis and Chronic Cough, Pancreatic Cancer and Stroke

  ()
Repurposing extends a drug's reach and value, and Algernon Pharmaceuticals' strategy of finding and demonstrating new uses for existing drugs reduces risk, accelerates time to market and increases capital efficiency. read more >

Cerevel Shares More Than Double on Positive Topline Results in Phase 1b Schizophrenia Trial

  ()
Shares of Cerevel Therapeutics hit a new 52-week high after the company released positive topline results for its CVL-231 in a Phase 1b clinical trial in schizophrenia patients. read more >

Intellia Shares Rise 49% on 'Landmark' Interim Results in Phase 1 ATTR Amyloidosis Trial

  ()
Intellia Therapeutics soared to a new 52-week high after the firm reported that in a Phase 1 clinical study with partner Regeneron, it had achieved "landmark clinical data" that demonstrated deep reduction in disease-causing protein after a single infusion of NTLA-2001, an investigational CRISPR therapy for transthyretin (ATTR) amyloidosis. read more >

Eli Lilly Receives FDA Breakthrough Therapy Designation for Alzheimer's Treatment

  ()
Eli Lilly and Co's shares traded 8% higher and reached a new 52-week high after the company reported the FDA granted its investigational antibody therapy donanemab Breakthrough Therapy designation for use in treating Alzheimer's disease. read more >
Showing Results: 1 to 25 of 92 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts